Physician profile
John Galgani
NPI 1265413249
$17,714.93
in general payments reported to CMS, 2019-2025
53 companies · $2,079 in 2025
The $2,079 reported for 2025 was more than what 98% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,933 · 2020: $1,328 · 2021: $3,697 · 2022: $775 · 2023: $3,832 · 2024: $2,071 · 2025: $2,079.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,034 · Consulting Fee: $1,948.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,034.15 |
| Consulting Fee | $1,948.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $5,004.91 | 2020-2025 | |
| Novo Nordisk INC | $3,065.90 | 2019-2025 | Wegovy, Sogroya |
| Sanofi Pasteur INC. | $2,287.79 | 2019-2025 | |
| Ascendis Pharma Endocrinology INC | $675.52 | 2022-2025 | Skytrofa |
| Glaxosmithkline, LLC. | $508.29 | 2019-2025 | Bexsero, Shingrix, Arexvy |
| Dexcom, INC. | $493.62 | 2020-2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor, Dexcom G6 Transmitter |
| Medtronic, INC. | $471.26 | 2023-2025 | Minimed 780g |
| Sanofi-Aventis U.S. LLC | $453.24 | 2019-2025 | |
| Corium, LLC | $394.65 | 2023-2024 | Azstarys |
| Pfizer INC. | $370.36 | 2019-2025 | |
| Tolmar, INC. | $358.48 | 2023-2025 | Fensolvi |
| Insulet Corporation | $350.59 | 2019-2025 | Omnipod |
| Beta Bionics, INC. | $337.29 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Neurocrine Biosciences, INC. | $329.45 | 2024-2025 | |
| Tris Pharma INC | $306.10 | 2019-2024 | Dyanavel Xr |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Galgani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.